Keenova Therapeutics plc - Company Profile
Powered by 
All the sales intelligence you need on Keenova Therapeutics plc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Keenova Therapeutics plc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Keenova Therapeutics plc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Keenova Therapeutics plc (Keenova) formerly Mallinckrodt Plc, develops, produces, markets, and distributes specialty pharmaceutical products and therapies. The company offers branded pharmaceutical products for autoimmune and rare diseases in specialty areas such as nephrology, rheumatology, neurology, pulmonology and ophthalmology. It also offers immunotherapy, oncology and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. It offers specialty generic drugs and active pharmaceutical ingredients. Keenova markets branded products directly to physicians, specialty pharmacies, hospitals and ambulatory surgical centers; and also distributes branded and generic products through a network of drug distributors, specialty pharmaceutical distributors, and retail pharmacy chains, among others. It has facilities in the US, Ireland, Japan, and other countries. Keenova is headquartered in Dublin, Ireland.
Headquarters
Ireland
Address
College Business & Technology Park, Cruiserath Road, Blanchardstown, Dublin, D15TX2V
Website
www.keenova.com
Telephone
35318207940
No of Employees
1,600
Industry
Pharmaceuticals and Healthcare
Revenue (2025)
$1.4B
Keenova Therapeutics plc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Specialty Brands: | Cellex |
| Repository Corticotropin Injection | Inomax |
| Nitricoxide | Ofirmev |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | New Products/Services | In September, Endo introduced ADRENALIN (epinephrine in 0.9% sodium chloride injection) premixed IV bags in three new concentrations, 2 mg/250 mL, 5 mg/250 mL (20 mcg/mL), and 10 mg/250 mL (40 mcg/mL). |
| 2025 | Acquisitions/Mergers/Takeovers | In August, the company merged with Endo, Inc. |
| 2024 | Divestiture | In December, the company sold its Therakos business to CVC Capital Partners Fund IX. |
Competitor Comparison
| Key Parameters | Keenova Therapeutics plc | Eli Lilly and Co | Merck & Co Inc | Bayer AG | Johnson Matthey Plc |
|---|---|---|---|---|---|
| Headquarters | Ireland | United States of America | United States of America | Germany | United Kingdom |
| City | Blanchardstown | Indianapolis | Rahway | Leverkusen | London |
| State/Province | Dublin | Indiana | New Jersey | Nordrhein-Westfalen | - |
| No. of Employees | 1,600 | 50,605 | 75,000 | 92,815 | 10,644 |
| Entity Type | Private | Public | Public | Public | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Marc Yoskowitz | Chairman | Executive Board | 2024 | 51 |
| Sigurdur Olafsson | President; Director; Chief Executive Officer | Executive Board | 2022 | 57 |
| Christiana Stamoulis | President; Chief Financial Officer | Senior Management | 2025 | - |
| Cheryl Stouch s | Executive Vice President; Chief Information Officer | Senior Management | - | - |
| Mark Tyndall | Executive Vice President; Corporate Secretary; Chief Legal Officer | Senior Management | 2022 | 48 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer